Search Results (14)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. | Academic Article |
Why?
|
Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model. | Academic Article |
Why?
|
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531. | Academic Article |
Why?
|
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group. | Academic Article |
Why?
|
Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. | Academic Article |
Why?
|
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. | Academic Article |
Why?
|
Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group. | Academic Article |
Why?
|
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. | Academic Article |
Why?
|
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group. | Academic Article |
Why?
|
Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa. | Academic Article |
Why?
|
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. | Academic Article |
Why?
|
iAmHealthy: Rationale, design and application of a family-based mHealth pediatric obesity intervention for rural children. | Academic Article |
Why?
|
Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. | Academic Article |
Why?
|
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. | Academic Article |
Why?
|